Figure 2.
Level of NOS isoforms [eNOS (Panel A), nNOS (Panel B), and iNOS (Panel C)] in non-ischemic NTg and FGF2 Tg hearts. Overexpression of FGF2 resulted in an increase in iNOS expression compared to NTg hearts, suggesting that overexpressing FGF2 in the heart modulates signaling pathways such as NOS and NO which are involved in cardioprotection. n = 4–6 hearts per group. *p < 0.05 vs. NTg.